Le ultime news oncologiche dall'Italia e dal mondo
RESPOND is the largest coordinated study on biological and non-biological factors associated with aggressive prostate cancer in African-American men. The study is an effort to learn why these men disproportionally experience aggressive disease.
Read more...Copertura media discreta se si confrontano i dati con altre nazioni europee, ma al di sotto della soglia ottimale prevista dal Piano Nazionale di Prevenzione Vaccinale (95%). Continua calo della copertura vaccinale per ciclo completoData di pubblicazione: 17/07/2018
Read more...
Language EnglishJuly 17, 2018claire.smithCancer.Net Associate Editors discuss exciting and practice-changing cancer research from ASCO Annual Meeting in this Research Round Up podcast.
News report The number of GP prescriptions for stop smoking aids in England has fallen by 75% in the last decade, according to new figures. A report by the British Lung foundation found that the number of stop smoking aids prescribed[…]
Science blog In the third and final part of our series on old age and cancer, we look at how research could help to adapt and improve treatment for older patients.Cancer is often described as a disease of ageing. And[…]
Confermato l’aumento progressivo delle donne con più di 40 anni che accedono alle tecniche di PMA: sono passate dal 20,7% del 2005 al 35,2% nel 2016Data di pubblicazione: 13/07/2018
Read more...Grant funding is supported by the NFL's Crucial Catch campaign
Read more...
Language SpanishJuly 12, 2018Sonja.HibbsDonar su cabello es una excelente manera de apoyar a las personas con cáncer que perdieron el suyo. Esto es todo lo que debe saber para empezar.
NCI and the Department of Veterans Affairs (VA) are launching the NAVIGATE program at 12 VA facilities across the country to make it easier for veterans to participate in NCI-sponsored clinical trials.
Read more...Eliminating socioeconomic disparity could prevent one in four cancer deaths in the United States
Read more...Results from a recent study show that some differences exist in NSCLC gene expression from African Americans and European Americans, which could be leveraged to improve patient outcome in both populations.
Read more...Researchers have identified mutations that may help distinguish which laryngeal cancer patients could benefit from therapy, since the disease is notoriously resistant to chemotherapeutic treatments.
Read more...
